drugset / Trial / NCT02160587

Safety Study to Evaluate the Contact Sensitizing Potential of Topically Applied ZuraPrep™ and ZuraPrep™ Without IPA

NCT02160587

Phase 1 Completed 208 enrolled Zurex Pharma, Inc.
NaSingle-groupDouble-blind

Summary

This is a safety study to determine the skin sensitization potential of ZuraPrep™ and ZuraPrep™ without isopropyl alcohol (IPA) after repetitive patch applications to skin of human subjects. Indications of both sensitization and skin irritation will be evaluated.

Timeline

Start
2014-07
Primary completion
2014-10
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Chlorhexidine Small molecule

Indications

No indication recorded.